Raman Bahal
Associate Professor/Pharmaceutical Science

Are you Raman Bahal?

How to update your information.
Scholarly Contributions

69 Scholarly Contributions

58
Journal Articles
8
Patent and Intellectual Propertys
2
Other Scholarly Works
1
Poster/Presentation
The growth of siRNA-based therapeutics: Updated clinical studies
2021
May Zhang, xiaobo zhong, Raman Bahal, Theodore Rasmussen, Jose E Manautou
Research Type: Journal Article

Dual-Modality Poly-l-histidine Nanoparticles to Deliver Peptide Nucleic Acids and Paclitaxel for In Vivo Cancer Therapy.
2021
S Malik, K C Shih, A Vikram, Yang Liu, Chi-ming Chen, A Wahane, Mu-ping Nieh, Raman Bahal, R R Gaddam
Research Type: Journal Article

Nanoparticle Delivered Anti-miR-141-3p for Stroke Therapy.
2021
R Verma, K Dhuri, R N Vyas, Raman Bahal, L Blumenfeld
Research Type: Journal Article

Extracellular vesicles mediated exocytosis of antisense peptide nucleic acids.
2021
Raman Bahal, W M Saltzman, S Malik
Research Type: Journal Article

Therapeutic Potential of Chemically Modified, Synthetic, Triplex Peptide Nucleic Acid-Based Oncomir Inhibitors for Cancer Therapy.
2021
R R Gaddam, K Dhuri, Raman Bahal, A Vikram, F J Slack
Research Type: Journal Article

PLA-HPG particles delivered multiple oncomiRs inhibitors for cancer treatment
2021
Raman Bahal
Research Type: Patent and Intellectual Property

Nanoparticle-mediated genome editing in single-cell embryos via peptide nucleic acids.
2022
Raman Bahal, P M Glazer, A S Ricciardi, W M Saltzman, R Putman, E Quijano
Research Type: Journal Article

New Technologies Bloom Together for Bettering Cancer Drug Conjugates.
2022
S Edalatian Zakeri, Y Jin, Andrew Wiemer, Raman Bahal
Research Type: Journal Article

Head on Comparison of Self- and Nano-assemblies of Gamma Peptide Nucleic Acid Amphiphiles.
2022
C H Liu, S Krueger, K C Shih, Mu-ping Nieh, S Malik, V Kumar, Raman Bahal
Research Type: Journal Article

Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis Regression.
2022
A Moshnikova, N L Price, O A Andreev, N Rotllan, C Fernández-Hernando, Y K Reshetnyak, Y Suárez, M M Sadeghi, Raman Bahal, Xinxuan Zhang, W Zhong, E Araldi, S Malik, A Canfrán-Duque, Jianjun Sun, J Toczek
Research Type: Journal Article

Adverse Drug Reactions and Toxicity of the Food and Drug Administration–Approved Antisense Oligonucleotide Drugs
2022
Kristy Zhang, Hangyu Wu, Rajvi Parikh, xiaobo zhong, Theodore Rasmussen, Feryal Alhamadani, Jose E Manautou, Raman Bahal
Research Type: Journal Article

Serine-γPNA, Invader probes, and chimeras thereof: three probe chemistries that enable sequence-unrestricted recognition of double-stranded DNA.
2022
Raman Bahal, R G Emehiser, C Shepard, S Karmakar, K Dhuri, P J Hrdlicka
Research Type: Journal Article

Absorption, Distribution, Metabolism, and Excretion of US Food and Drug Administration–Approved Antisense Oligonucleotide Drugs
2022
Sunna Liu, xiaobo zhong, Sreenidhi Nair, Theodore Rasmussen, Anna Liu, Anagha Gogate, Raman Bahal, Julia M Migliorati, Jose E Manautou
Research Type: Journal Article

γ Peptide Nucleic Acid-Based miR-122 Inhibition Rescues Vascular Endothelial Dysfunction in Mice Fed a High-Fat Diet.
2022
K Irani, Q Li, V Kumar, Yusun Kim, J S Jacobs, A Vikram, Raman Bahal, K Dhuri, R R Gaddam
Research Type: Journal Article

Casimersen for the treatment of Duchenne muscular dystrophy.
2022
Raman Bahal, S P Pradeep, Jose E Manautou, V Kasina, A P Laddha, S E Zakeri
Research Type: Journal Article

Simultaneous targeting of multiple oncomiRs with phosphorothioate or PNA-based anti-miRs in lymphoma cell lines
2022
Raman Bahal, Karishma Dhuri, Xiaobo Zhong, Sai Pallavi Pradeep, Frank J Slack, Jason Shi, Anisha Gupta, Eleni Anastasiadou
Research Type: Journal Article

Nephrotoxicity of marketed antisense oligonucleotide drugs
2022
Feryal Alhamadani, Rajvi Parikh, Theodore Rasmussen, Evan M McCabe, SooWan Lee, Xiaobo Zhong, Jose E Manautou, Aniket Wahane, Hangyu Wu, Raman Bahal, Kristy Zhang
Research Type: Journal Article

Nanoparticle delivery systems for substance use disorder.
2022
R J Mownn, Raman Bahal, V Kasina, Gregory Sartor
Research Type: Journal Article

Nedosiran, a Candidate siRNA Drug for the Treatment of Primary Hyperoxaluria: Design, Development, and Clinical Studies
2022
Theodore Rasmussen, Jenny Zhao, Julia M. Migliorati, Raman Bahal, Jose E Manautou, Milan Shah, Anna Liu, Sherouk M. Tawfik, Xiao Bo Zhong
Research Type: Other Scholarly Work

Dual-modality poly-L-histidine nanoparticles to deliver peptide nucleic acids and paclitaxel for in vivo cancer therapy
2022
Raman Bahal
Research Type: Patent and Intellectual Property